Skip to content

The efficacy of a multidisciplinary treatment program in patients with osteoarthritis of the hands.

The Nijmegen randomised, singleblind, controlled trial on the effect of a multidisciplinary treatment programme in patients with OsteoArthritis of the Hands (NOAH).

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26321
Enrollment
150
Registered
2007-12-21
Start date
2008-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand osteoarthritis (NLD: handartrose).

Interventions

9. Referral for a splint if considered necessary by the occupational therapist. Control: education and instruction about exercises (30 minutes session).
Experimental: The multidisciplinary treatment program consists of an intake by an occupational therapist, followed by 4 group sessions (6-8 patients) of 2,5 hours. During the intake an occupational
2. Education about OA and treatment options (medication, aids, splints, exercise)
3. Providing insight in the relation of daily activities versus pain, fatigue and limitations in activities by means of discussing diaries
4. Discussion and reflection on strategies to cope with pain, fatigue and limitations in activities (balance between rest and physical activity, individual use of medication, use of compensatory strat
5. Strategies to communicate with others
6. Formulating measures and actions to achieve individual goals
7. Exercises to improve strength and hand mobility
8. Practice of the use of household activities

Sponsors

Rheumatology Centre, Sint Maartenskliniek, Postbus 9011, 6500 GM Nijmegen tel. 024-365 9984
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Referred for multidisciplinary treatment in one of the participating centres; 2. OA of the hand according to the ACR classification criteria; 3. AUSCAN score > 1; 4. Limitation in activities due to hand OA is the most or second most important problem for the patient; 5. Willing to participate in a group treatment program.

Exclusion criteria

Exclusion criteria: 1. Other inflammatory diseases such as rheumatoid arthritis, arthritis psoriatica; 2. Carpal tunnel syndrome; 3. Joint arthroplasty in one or more of the joints of the hand/wrist; 4. Diagnosis of fibromyalgia.

Design outcomes

Primary

MeasureTime frame
1. AUSCAN (Handfunction); 2. OARSI responders criteria.

Secondary

MeasureTime frame
1. Visual analogue scale for pain, stiffness and tiredness; 2. Tender joint count of hand and wrist joints rated according to Ritchie; 3. Joint mobility: hand and wrist joints, measured according to the EMP-ROM; a measure to assess joint mobility in rheumatoid arthritis (Vliet Vlieland et al, 1992); 4. Grip and pinch strength; assessed on a Jamar Dynamometer; 5. Dutch- AIMS: subscales for hand and finger function; impact of hand OA; 6. Arthritis self efficacy scale (Lorig et al, 1989); 7. Self perceived change (on 8 point Likert scale); 8. Canadian Occupational Performance measure: a measure of a client's self-perception of performance in the areas of self-care, productivity and leisure, validated in Dutch patients (Dedding et al, 2004); -SF-36: a generic questionnaire to assess quality of life.

Contacts

Public ContactC.H.M. Ende, van den

Sint Maartenskliniek, Dept. Reumaresearch, PO box 9011

e.vandenende@maartenskliniek.nl+31 (0)243659984

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)